Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
325 articles on this topic
-
TAZPOWER Trial: What the Results Actually Show
TAZPOWER missed its main walking and fatigue goals against placebo. Longer follow-up reported gains, with enough uncertainty to require another trial.
-
1984 Nobel Prize in Chemistry: Making Peptides
Bruce Merrifield’s bead method made peptides easier to build. The breakthrough explains modern synthesis—and why purity testing still matters.
-
Compounded Semaglutide China Alert: What It Means Now
Recent compounded semaglutide China reports trace back to two raw-ingredient factories placed on an FDA border-hold list. Here is what the alert covers, how U.S. pharmacy sourcing rules work, and what patients can ask.
-
Epitalon News Update: October 2026
July brought favorable advisory votes and a new cancer-cell study. Here is what changed for epitalon, what the FDA’s current pages say, and what remains unproven in people.
-
FDA Peptide Policy: Under Review, Not in Effect Yet
The White House logged a new FDA peptide policy notice on October 14, 2026, but the text is not public yet. Here is what the official record confirms, what unnamed sources reported about BPC-157, and what stays the same today.
-
BPC-157 for Ligaments: Animal Evidence, Human Gaps
The ligament claim comes from a rat knee study. Human trials have not shown that BPC-157 repairs an ACL tear or shortens recovery from a sprain.
-
Does Tirzepatide Cause Headaches? What Trials Show
Headaches occurred in about 7 in 100 people in SURMOUNT-1, with similar rates on placebo. Fluid loss, missed meals, and other medicines can still matter.
-
Epitalon for Sleep: Better Sleep Isn't Established
Epitalon has been studied for melatonin production, but better sleep hasn't been demonstrated in people. The small human study measured a hormone marker.
-
MMPOWER-3 Trial: Walking and Fatigue Goals Not Met
After 24 weeks, elamipretide did not beat placebo on walking distance or fatigue. A later genetic subgroup finding led to another trial, not a new verdict.
-
Semaglutide and Cholesterol: What Changes?
Semaglutide trials found small cholesterol changes and a larger drop in triglycerides, another blood fat. Those results don’t replace prescribed cholesterol treatment.
-
Thymosin Alpha 1 Sepsis Trial: What TESTS Found
TESTS found no clear reduction in sepsis deaths: 23.4% with thymosin alpha-1 versus 24.1% with placebo. Its subgroup findings remain tentative.
-
STRIDE Trial Semaglutide: Walking Results
Semaglutide was associated with better treadmill walking in people with leg artery disease and type 2 diabetes. Here are the numbers, side effects and limits of STRIDE.
-
CJC-1295 Ipamorelin News: October 2026
The quarter brought a new WADA list, online-product notices and an evidence review. The two molecules still have different FDA records and limited human outcome data.
-
What Is Bacteriostatic Water? Meaning and Safety
Bacteriostatic water contains a preservative that limits bacterial growth. The medication’s instructions decide whether it is the right mixing liquid.
-
Egrifta Prescribing Information, Explained
Egrifta WR’s label covers one HIV-related use, a daily dose, four contraindications, monitoring, side effects, and product-specific storage. WR and SV directions cannot be swapped.
-
10 Questions to Ask Before BPC-157
Ten questions explain what a BPC-157 visit needs to cover, from medical history and evidence limits to sport testing and follow-up.
-
Sermorelin Myths: 10 Claims Checked
Sermorelin can stimulate growth-hormone release. Ten familiar claims about aging, muscle, sleep and safety go further than the human studies support.
-
1977 Nobel Prize in Medicine: Peptide Discoveries
Three scientists shared the prize for finding the brain’s hormone messages and making tiny hormone levels measurable. Here’s how that history connects to today’s prescriptions.
-
Who Discovered Ghrelin? Kojima and Kangawa
Masayasu Kojima, Kenji Kangawa and colleagues identified ghrelin in 1999. Earlier peptide and receptor discoveries set up the finding; appetite studies followed.
-
Who Discovered Semax? Its Russian Origins
Igor Ashmarin, Nikolai Myasoedov and a Moscow team developed Semax. Its history runs from modified hormone fragments to Russian registration and U.S. review.
Page 1 of 17 · 325 articles